# Concomitant and Sequential Radiohormonotherapy in Adjuvant Breast Cancer

> **NCT00208273** · PHASE2 · COMPLETED · sponsor: **Institut du Cancer de Montpellier - Val d'Aurelle** · enrollment: 150 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Letrozole - Concomitant
- **DRUG:** Letrozole - Sequential

## Key facts

- **NCT ID:** NCT00208273
- **Lead sponsor:** Institut du Cancer de Montpellier - Val d'Aurelle
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2007-01
- **Final completion:** 2007-02
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2021-06-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00208273

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00208273, "Concomitant and Sequential Radiohormonotherapy in Adjuvant Breast Cancer". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00208273. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*